Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

GROWTH-HORMONE RESPONSE TO GROWTH-HORMONE RELEASING HORMONE IN DEPRESSION AND SCHIZOPHRENIA PSYCHIATRY RESEARCH Peabody, C. A., Warner, M. D., Markoff, E., Hoffman, A. R., Wilson, D. M., Csernansky, J. G. 1990; 33 (3): 269-276

Abstract

Growth hormone releasing hormone, a 44-amino acid peptide (GHRH-44), was administered (1 micrograms/kg i.v.) to 6 normal controls, 10 schizophrenic subjects, and 7 depressed subjects. A significantly lower growth hormone (GH) response was found in the schizophrenic and depressed groups. Two molecular forms of GH, 22K GH and 20K GH, were also measured but did not further differentiate the three groups of subjects.

View details for Web of Science ID A1990EA31200006

View details for PubMedID 2243902